{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,3,14]],"date-time":"2026-03-14T16:01:04Z","timestamp":1773504064539,"version":"3.50.1"},"reference-count":14,"publisher":"Oxford University Press (OUP)","issue":"3","license":[{"start":{"date-parts":[[2023,2,15]],"date-time":"2023-02-15T00:00:00Z","timestamp":1676419200000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by-nc\/4.0\/"}],"content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":[],"published-print":{"date-parts":[[2023,3,6]]},"abstract":"<jats:title>Abstract<\/jats:title><jats:sec><jats:title>Background<\/jats:title><jats:p>Cardiac ascites is a classical finding of right-sided heart failure, mainly caused by tricuspid valve disease and constrictive pericarditis. Refractory cardiac ascites, defined as ascites that is uncontrollable with any medication, including conventional diuretics and selective vasopressin V2 receptor antagonists, is a rare but challenging entity. Although cell-free and concentrated ascites reinfusion therapy (CART) is a therapeutic option for refractory ascites in patients with liver cirrhosis and malignancy, its efficacy in cardiac ascites has never been reported. We herein report a case of CART for refractory cardiac ascites in a patient with complex adult congenital heart disease (ACHD).<\/jats:p><\/jats:sec><jats:sec><jats:title>Case summary<\/jats:title><jats:p>A 43-year-old Japanese female with a history of ACHD involving single ventricle haemodynamics presented with refractory massive cardiac ascites due to progressive heart failure. Because conventional therapy using diuretics could not control her cardiac ascites, abdominal paracentesis was frequently required, resulting in hypoproteinaemia. Therefore, CART was initiated once per month in addition to conventional therapies, which enabled the prevention of hypoproteinaemia and further hospitalizations except to undergo CART. In addition, it helped improve her quality of life without any complications for 6 years until she died from cardiogenic cerebral infarction at the age of 49 years.<\/jats:p><\/jats:sec><jats:sec><jats:title>Discussion<\/jats:title><jats:p>This case demonstrated that CART can be safely performed in patients with complex ACHD and refractory cardiac ascites due to advanced heart failure. Thus, CART may improve refractory cardiac ascites as effectively as massive ascites caused by liver cirrhosis and malignancy and lead to an improvement in the patients\u2019 quality of life.<\/jats:p><\/jats:sec>","DOI":"10.1093\/ehjcr\/ytad081","type":"journal-article","created":{"date-parts":[[2023,2,15]],"date-time":"2023-02-15T07:39:05Z","timestamp":1676446745000},"source":"Crossref","is-referenced-by-count":1,"title":["Cell-free and concentrated ascites reinfusion therapy for refractory massive cardiac ascites in an adult with single ventricle haemodynamics: a case report"],"prefix":"10.1093","volume":"7","author":[{"given":"Yasue","family":"Tsukishiro","sequence":"first","affiliation":[{"name":"Division of Cardiovascular Medicine, Department of Internal Medicine, Hyogo Prefectural Harima-Himeji General Medical Center , 3-264 Kamiya-cho, Himeji , Japan"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-5268-4606","authenticated-orcid":false,"given":"Hiroyuki","family":"Yamamoto","sequence":"additional","affiliation":[{"name":"Division of Cardiovascular Medicine, Department of Internal Medicine, Hyogo Prefectural Harima-Himeji General Medical Center , 3-264 Kamiya-cho, Himeji , Japan"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-0519-7178","authenticated-orcid":false,"given":"Akiko","family":"Masumoto","sequence":"additional","affiliation":[{"name":"Division of Cardiovascular Medicine, Department of Internal Medicine, Hyogo Prefectural Harima-Himeji General Medical Center , 3-264 Kamiya-cho, Himeji , Japan"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"ORCID":"https:\/\/orcid.org\/0000-0001-5775-8072","authenticated-orcid":false,"given":"Tomofumi","family":"Takaya","sequence":"additional","affiliation":[{"name":"Division of Cardiovascular Medicine, Department of Internal Medicine, Hyogo Prefectural Harima-Himeji General Medical Center , 3-264 Kamiya-cho, Himeji , Japan"},{"name":"Department of Exploratory and Advanced Research in Cardiology, Kobe University Graduate School of Medicine , Kobe , Japan"}],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"286","published-online":{"date-parts":[[2023,2,15]]},"reference":[{"key":"2023030719232507200_","first-page":"e10995","article-title":"Spontaneous bacterial peritonitis in cardiogenic ascites","volume":"12","author":"Zafar","year":"2020","journal-title":"Cureus"},{"key":"2023030719232507200_","doi-asserted-by":"crossref","first-page":"e0177303","DOI":"10.1371\/journal.pone.0177303","article-title":"Safety and efficacy of cell-free and concentrated ascites reinfusion therapy (CART) in refractory ascites: post-marketing surveillance results","volume":"12","author":"Hanafusa","year":"2017","journal-title":"PLoS One"},{"key":"2023030719232507200_","doi-asserted-by":"crossref","first-page":"3069","DOI":"10.2169\/internalmedicine.3091-19","article-title":"Cell-free and concentrated ascites reinfusion therapy for refractory ascites in cirrhosis in post-marketing surveillance and the role of tolvaptan","volume":"58","author":"Iwasa","year":"2019","journal-title":"Intern Med"},{"key":"2023030719232507200_","doi-asserted-by":"crossref","first-page":"218","DOI":"10.1186\/s12885-022-09336-3","article-title":"Feasibility of a fast-track randomized controlled trial of cell-free and concentrated ascites reinfusion therapy for patients with refractory malignant ascites","volume":"22","author":"Yokomichi","year":"2022","journal-title":"BMC Cancer"},{"key":"2023030719232507200_","doi-asserted-by":"crossref","first-page":"4873","DOI":"10.3390\/cancers13194873","article-title":"Effectiveness of cell-free and concentrated ascites reinfusion therapy in the treatment of malignancy-related ascites: a systematic review and meta-analysis","volume":"13","author":"Chen","year":"2021","journal-title":"Cancers (Basel)"},{"key":"2023030719232507200_","doi-asserted-by":"crossref","first-page":"2497","DOI":"10.2169\/internalmedicine.8799-21","article-title":"Proliferative glomerulonephritis with monoclonal IgG deposits and refractory ascites: successful treatment with rituximab and cell-free and concentrated ascites reinfusion therapy","volume":"61","author":"Takami","year":"2022","journal-title":"Intern Med"},{"key":"2023030719232507200_","doi-asserted-by":"crossref","first-page":"699","DOI":"10.1097\/00002480-197700230-00189","article-title":"Treatment of intractable ascites by continuous reinfusion of the sterilized, cell-free and concentrated ascitic fluid","volume":"23","author":"Inoue","year":"1977","journal-title":"Trans Am Soc Artif Intern Organs"},{"key":"2023030719232507200_","doi-asserted-by":"crossref","first-page":"376","DOI":"10.1111\/1744-9987.12469","article-title":"Cell-free and concentrated ascites reinfusion therapy for decompensated liver cirrhosis","volume":"20","author":"Kozaki","year":"2016","journal-title":"Ther Apher Dial"},{"key":"2023030719232507200_","doi-asserted-by":"crossref","first-page":"87","DOI":"10.1111\/1744-9987.12049","article-title":"Single center experience of cell-free and concentrated ascites reinfusion therapy in malignancy related ascites","volume":"18","author":"Ito","year":"2014","journal-title":"Ther Apher Dial"},{"key":"2023030719232507200_","doi-asserted-by":"crossref","first-page":"467","DOI":"10.1002\/jcu.23177","article-title":"Long-term survival of patients with unoperated single ventricle heart defect: four case reports and literature review","volume":"50","author":"Zhao","year":"2022","journal-title":"J Clin Ultrasound"},{"key":"2023030719232507200_","doi-asserted-by":"crossref","first-page":"5861","DOI":"10.1007\/s00520-020-05401-4","article-title":"Safety and efficacy of cell-free and concentrated ascites reinfusion therapy (CART) in gastrointestinal cancer patients with massive ascites treated with systemic chemotherapy","volume":"28","author":"Nagata","year":"2020","journal-title":"Support Care Cancer"},{"key":"2023030719232507200_","doi-asserted-by":"crossref","first-page":"268","DOI":"10.1186\/s12885-022-09298-6","article-title":"Adverse effects of cell-free and concentrated ascites reinfusion therapy for malignant ascites: a single-institute experience","volume":"22","author":"Tsubokura","year":"2022","journal-title":"BMC Cancer"},{"key":"2023030719232507200_","doi-asserted-by":"crossref","first-page":"1437","DOI":"10.1111\/liv.13712","article-title":"Acute kidney injury, but not sepsis, is associated with higher procedure-related bleeding in patients with decompensated cirrhosis","volume":"38","author":"Hung","year":"2018","journal-title":"Liver Int"},{"key":"2023030719232507200_","doi-asserted-by":"crossref","first-page":"651","DOI":"10.1002\/lt.25724","article-title":"Improvement in quality of life and decrease in large-volume paracentesis requirements with the automated low-flow ascites pump","volume":"26","author":"Wong","year":"2020","journal-title":"Liver Transpl"}],"container-title":["European Heart Journal - Case Reports"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/academic.oup.com\/ehjcr\/advance-article-pdf\/doi\/10.1093\/ehjcr\/ytad081\/49182821\/ytad081.pdf","content-type":"application\/pdf","content-version":"am","intended-application":"syndication"},{"URL":"https:\/\/academic.oup.com\/ehjcr\/article-pdf\/7\/3\/ytad081\/49435997\/ytad081.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"syndication"},{"URL":"https:\/\/academic.oup.com\/ehjcr\/article-pdf\/7\/3\/ytad081\/49435997\/ytad081.pdf","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2023,3,25]],"date-time":"2023-03-25T09:02:58Z","timestamp":1679734978000},"score":1,"resource":{"primary":{"URL":"https:\/\/academic.oup.com\/ehjcr\/article\/doi\/10.1093\/ehjcr\/ytad081\/7036868"}},"subtitle":[],"editor":[{"given":"Filippo","family":"Puricelli","sequence":"additional","affiliation":[],"role":[{"role":"editor","vocabulary":"crossref"}]},{"given":"Luis Antonio","family":"Moreno-Ruiz","sequence":"additional","affiliation":[],"role":[{"role":"editor","vocabulary":"crossref"}]},{"given":"Christoph Clemens","family":"Kaufmann","sequence":"additional","affiliation":[],"role":[{"role":"editor","vocabulary":"crossref"}]},{"given":"Franca","family":"Morselli","sequence":"additional","affiliation":[],"role":[{"role":"editor","vocabulary":"crossref"}]},{"given":"Tom","family":"Wardill","sequence":"additional","affiliation":[],"role":[{"role":"editor","vocabulary":"crossref"}]}],"short-title":[],"issued":{"date-parts":[[2023,2,15]]},"references-count":14,"journal-issue":{"issue":"3","published-print":{"date-parts":[[2023,3,6]]}},"URL":"https:\/\/doi.org\/10.1093\/ehjcr\/ytad081","relation":{},"ISSN":["2514-2119"],"issn-type":[{"value":"2514-2119","type":"electronic"}],"subject":[],"published-other":{"date-parts":[[2023,3,1]]},"published":{"date-parts":[[2023,2,15]]},"article-number":"ytad081"}}